Lynestrenol

Specifications

52-76-6CAS Number

200-151-4EC Number

(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-olIUPAC Name

C20H28OChemical Formula

284.4 g/molMolecular Weight

LYNESTRENOL; 52-76-6; Linestrenol; Ethinylestrenol; Lynoestrenol; Orgametril; Ethynylestrenol; Orgametil; 3-Desoxynorlutin; NSC-37725; Linestrenolo; Lynestrenolum; 17alpha-Ethynylestrenol; DTXSID4021478; 19-Nor-17alpha-pregn-4-en-20-yn-17-ol; N2Z8ALG4U5; NSC37725; 19-norpregn-4-en-20-yn-17alpha-ol; DTXCID501474457; Linesterol; RefChem:800197; G03AC02; G03DC03; 200-151-4; Orgametrol; Exluton; Exlutona; Endometril; Exlution; Org 485-50; IND 1006; MFCD00051135; 17.alpha.-Ethynylestrenol; (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol; Exluten; 17alpha-Ethynyl-19-nor-4-androsten-17beta-ol; 19-Norpregn-4-en-20-yn-17-ol, (17a)-; 19-Norpregn-4-en-20-yn-17-ol, (17.alpha.)-; Ethynloestrenol; Estr-4-en-17.beta.-ol, 17-ethynyl-; Lynenol; Lynstranol; Ethinyloestranol; Ethinyl oestrenol; 19-Norpregn-4-en-20-yn-17-ol, (17alpha)-; 19-Nor-17.alpha.-pregn-4-en-20-yn-17-ol; .DELTA.4-17.alpha.-Ethinylestren-17.beta.-ol; Linestrenolo [DCIT]; 17-alpha-Ethynylestrenol; 17-alpha-Ethynyloestrenol; Linestrenol [INN-Spanish]; Lynestrenolum [INN-Latin]; CCRIS 9093; EINECS 200-151-4; Lynoestrenol [Progestins]; NSC 37725; Estr-4-en-17beta-ol, 17-ethynyl-; UNII-N2Z8ALG4U5; 17-alpha-Ethynylestr-4-en-17-beta-ol; delta4-17alpha-Ethinylestren-17beta-ol; 17-alpha-Ethynyloestr-4-en-17-beta-ol; Lynestrenol CRS; 17-alpha-Ethinyl-17-beta-hydroxyestr-4-ene; 17-alpha-Ethinyl-17-beta-hydroxyoestr-4-ene; HSDB 7899; 17-alpha-Ethynil-delta-4-estrene-17-beta-ol; (17-alpha)-19-Norpregn-4-en-20-yn-17-ol; CAS-52-76-6; delta(sup 4)-17-alpha-Ethinylestren-17-beta-ol; NCGC00016233-01; (1R,3aS,3bR,9aR,9bS,11aS)-1-ethynyl-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol; delta(sup 4)-17-alpha-Ethinyloestren-17-beta-ol; Lynestrenol [USAN:INN:BAN:JAN]; Prestwick_533; NSC-73879; LYNESTRENOL [MI]; Prestwick0_000095; Prestwick1_000095; Prestwick2_000095; Prestwick3_000095; LYNESTRENOL [INN]; LYNESTRENOL [JAN]; Lynestrenol (JAN/USAN); LYNESTRENOL [USAN]; 19-Nor-17-alpha-pregn-4-en-20-yn-17-ol; LYNESTRENOL [MART.]; 19 Norpregn-4-en-20-yn-17-ol, (17alpha)-; SCHEMBL37816; BSPBio_000050; LYNESTRENOL [USP-RS]; LYNESTRENOL [WHO-DD]; SPBio_001989; 17-Ethynylestr-4-en-17-ol; BPBio1_000056; CHEMBL2107431; CHEBI:31790; HMS1568C12; HMS2095C12; HMS3712C12; LYNESTRENOL [EP MONOGRAPH]; NSC73879; Tox21_110319; Tox21_301969; LMST02030127; s4883; ST 20:3;O; AKOS024462708; Tox21_110319_1; 19-Nor-4-pregnen-20-yn-17beta-ol; CCG-220095; DB12474; FL35098; Lynestrenol for peak identification CRS; MSK161816-100A; NCGC00179676-01; NCGC00179676-03; NCGC00255262-01; 17alpha-19-Norpregn-4-en-20-yn-17-ol; CS-0032008; L0246; NS00003323; 17|A-Ethynyl-19-nor-4-androsten-17|A-ol; C75475; D01580; Lynestrenol Solution in Acetonitrile, 100ug/mL; F462718; Q2071071; BRD-K39707084-001-04-1; BRD-K39707084-001-05-8; 19 NORPREGN-4-EN-20-YN-17-OL, (17.ALPHA.)-; Lynestrenol Working Standard (Secondary Reference Standard); (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-olSynonyms